Remdesivir survival rate only 5% better than placebo: Study

The cornerstone of the nationwide hospital treatment protocol handed down by Fauci and the NIH is the antiviral drug remdesivir, which reportedly “can kill SARS-CoV-2 in a petri dish under experimental conditions.”1 A study in the New England Journal of Medicine, Remdesivir for the Treatment of Covid-19 — Final Report, found that “remdesivir was superiorContinue reading “Remdesivir survival rate only 5% better than placebo: Study”